Myriad Genetics Inc. (MYGN)
NASDAQ · Healthcare
Myriad Genetics Inc. Long Term Debt 2009–2025
Myriad Genetics Inc. annual long term debt history from 2017 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Myriad Genetics Inc. long term debt as of December 31, 2025: 119.9M, a 202.78% increase year-over-year.
- Myriad Genetics Inc. long term debt for 2025 were 119.9M, a 202.78% increase from 2024.
- Myriad Genetics Inc. long term debt for 2024 were 39.6M, a 2.86% increase from 2023.
- Myriad Genetics Inc. long term debt for 2023 were 38.5M, a 82.87% decrease from 2020.
- Myriad Genetics Inc. long term debt for 2020 were 224.8M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Myriad Genetics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $120 |
| 2024 | $40 |
| 2023 | $39 |
| 2020 | $225 |
| 2019 | $234 |
| 2018 | $9 |
| 2017 | $99 |
Myriad Genetics Inc. Long Term Debt — FAQ
Myriad Genetics Inc. (MYGN) long term debt over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MYGN's long term debt history?
The chart and table above show Myriad Genetics Inc.'s long term debt by year and by quarter, including the growth rate.